Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
$0.00
$0.00
$0.00
N/A1.910 shsN/A
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$1.37
+2.2%
$1.55
$1.14
$73.75
$229K-0.471.02 million shs166,073 shs
NEPTF
Neptune Wellness Solutions
$0.02
$0.00
$0.12
$23K-2.73,696 shs1 shs
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
$3.72
-1.6%
$4.51
$2.51
$2,592.00
$160K1.51175,570 shs10,754 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
0.00%0.00%0.00%+200.00%+200.00%
Bon Natural Life Limited stock logo
BON
Bon Natural Life
+2.24%0.00%-22.60%-52.76%-97.53%
NEPTF
Neptune Wellness Solutions
0.00%0.00%0.00%+400.00%+499,900.00%
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
-1.56%-9.24%-19.98%-23.91%-99.74%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
N/AN/AN/AN/AN/AN/AN/AN/A
Bon Natural Life Limited stock logo
BON
Bon Natural Life
N/AN/AN/AN/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
N/AN/AN/AN/AN/AN/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
0.00
N/AN/AN/A
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.00
N/AN/AN/A
NEPTF
Neptune Wellness Solutions
2.00
HoldN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
N/AN/AN/AN/AN/AN/A
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$23.84M0.01$1.76 per share0.78$37.78 per share0.04
NEPTF
Neptune Wellness Solutions
$52.62M0.00N/AN/A($91.90) per share0.00
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
$23.02M0.01N/AN/A$163.50 per share0.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$400KN/A0.00N/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
-$60.46M-$106.72N/AN/AN/AN/AN/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
-$6.16MN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
N/AN/AN/AN/AN/A
Bon Natural Life Limited stock logo
BON
Bon Natural Life
N/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
N/AN/AN/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
N/AN/AN/A
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.02
2.42
2.32
NEPTF
Neptune Wellness Solutions
N/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
N/A
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.57%
NEPTF
Neptune Wellness Solutions
11.72%
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.18%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amarantus Bioscience Holdings Inc. stock logo
AMBS
Amarantus Bioscience
12N/AN/ANot Optionable
Bon Natural Life Limited stock logo
BON
Bon Natural Life
100167,000863,000Not Optionable
NEPTF
Neptune Wellness Solutions
1304.53 million4.30 millionN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
22043,000731,000Not Optionable

Recent News About These Companies

UPC’s Unexpected Plunge: What’s Next?
Universe Pharmaceuticals gets Nasdaq delisting notice

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amarantus Bioscience stock logo

Amarantus Bioscience OTCMKTS:AMBS

Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company's diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer's disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a small molecule drug for the treatment of Parkinson's disease Levadopa-Induced Dyskinesia and attention deficit hyperactivity disorders; and mesencephalic-astrocyte-derived neurotrophic factor for the treatment of various animal models, including retinitis pigmentosa and retinal artery occlusion. It also develops NuroPro, a neurodegenerative disease diagnostic platform with application in Parkinson's disease; BC-SeraPro, an oncology diagnostic platform with application in breast cancer; and PhenoGuard platform for neurrotrophic factor discovery. In addition, the company develops Engineered Skin Substitute (ESS), a cell therapy-based autologous skin replacement product that is in mid-stage clinical development for the treatment of life-threatening severe burns. Amarantus BioScience Holdings, Inc. has a cooperative research and development agreement with the U.S. Army Institute of Surgical Research and Rutgers University. The company was formerly known as Amarantus Bioscience, Inc. and changed its name to Amarantus BioScience Holdings, Inc. in April 2013. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York.

Bon Natural Life stock logo

Bon Natural Life NYSE:BON

$1.37 +0.03 (+2.24%)
Closing price 06/26/2025 04:00 PM Eastern
Extended Trading
$1.34 -0.03 (-1.82%)
As of 04:45 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. It offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is based in Xi'an, the People's Republic of China.

Neptune Wellness Solutions OTC:NEPTF

Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga Neutraceuticals, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, and NurturMe brands. The company offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It is also involved in the extraction, purification, formulation, and manufacturing of health and wellness products, such as omega-3 and hemp-derived products under various delivery forms, such as soft gels, liquids, capsules, vape pens, sprays, topicals, sachets, tinctures, concentrates, edibles, and beverages, as well as hand sanitizers, non-contact thermometers, and gloves. In addition, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.

Universe Pharmaceuticals stock logo

Universe Pharmaceuticals NYSE:UPC

$3.72 -0.06 (-1.56%)
Closing price 06/26/2025 03:58 PM Eastern
Extended Trading
$3.68 -0.05 (-1.24%)
As of 06/26/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.